chr22-39100412-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181773.5(APOBEC3H):c.134G>T(p.Gly45Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000317 in 1,613,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181773.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
APOBEC3H | NM_181773.5 | c.134G>T | p.Gly45Val | missense_variant | 2/5 | ENST00000442487.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
APOBEC3H | ENST00000442487.8 | c.134G>T | p.Gly45Val | missense_variant | 2/5 | 3 | NM_181773.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000215 AC: 54AN: 251154Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135826
GnomAD4 exome AF: 0.000324 AC: 473AN: 1461312Hom.: 0 Cov.: 32 AF XY: 0.000321 AC XY: 233AN XY: 726880
GnomAD4 genome AF: 0.000250 AC: 38AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2023 | The c.134G>T (p.G45V) alteration is located in exon 2 (coding exon 1) of the APOBEC3H gene. This alteration results from a G to T substitution at nucleotide position 134, causing the glycine (G) at amino acid position 45 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at